$12.69
-4.3%Nuveen Churchill Direct Lending Corp. (the Company) is business development company and was formed on March 13, 2018, as a limited liability company under the laws of the State of Delaware and was converted into a Maryland corporation on June 18, 2019 prior to the commencement of operations. The Company is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (BDC) under the Investment Company Act of 1940, as amended (the 1940 Act). The Company's investment objective is to generate attractive risk-adjusted returns primarily through current income by investing primarily in senior secured loans to private equity-owned U.S. middle market companies, which the Company defines as companies with approximately $10.0 million to $100.0 million of earnings before interest, taxes, depreciation and amortization (EBITDA). The Company will focus on privately originated debt to performing U.S. middle market companies, with a portfolio expected to comprise primarily of first-lien senior secured debt and unitranche loans (other than last-out positions in unitranche loans) (collectively Senior Loans). The Company will also opportunistically invest in junior capital opportunities (second-lien loans, subordinated debt, last-out positions in unitranche loans and equity-related securities) (collectively Junior Capital Investments).
Chief Compliance Officer
Chief Executive Officer
Chief Executive Officer, President & Chairman
Chief Financial Officer & Treasurer
Director of Human Resources
Head of Junior Capital & Private Equity Solutions
MD and Head of Marketing & Communications
Managing Director of Business Development
Managing Director of Product Development & Investor Relations
Vice President & Deputy General Counsel
During the last 12 months, insiders have purchased $1.33M worth of NCDL shares, with no selling activity reported.
33.6K
452.53K
0
0.00
+453K
+$453K
19.7K
260.02K
0
0.00
+260K
+$260K
32.0K
457.85K
0
0.00
+458K
+$458K
9.6K
156.41K
0
0.00
+156K
+$156K
Kencel Kenneth J.
Director, Officer: Ceo & President
$415K
Vichness Shaul
Officer: Chief Financial Off./Treasurer
$358K
Ritchie James Joseph
Director
$245K
Hassen Marissa
Officer: Chief Accounting Officer
$125K
Strife Jason
Other: Member-Sub-Adv'S Joint Inv Com
$103K
No selling activity
Strong bullish signal with $1.33M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
NCDL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 07, 2026 | May 21, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 11, 2025 | May 29, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 15, 2024 | April 15, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | November 27, 2023 | November 27, 2023 | 2023 | |
DEF 14A DEF 14A 2023 N/A | April 04, 2023 | May 18, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 07, 2022 | April 07, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 05, 2021 | April 05, 2021 | 2021 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.